Limonte Christine P, Prince David K, Hoofnagle Andrew N, Hirsch Irl B, Waikar Sushrut S, Doria Alessandro, Mauer Michael, Kestenbaum Bryan R, de Boer Ian H
Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington, USA.
Kidney Research Institute, Department of Medicine, University of Washington, Seattle, Washington, USA.
Kidney Int Rep. 2025 May 6;10(7):2311-2322. doi: 10.1016/j.ekir.2025.04.057. eCollection 2025 Jul.
Kidney tubular biomarker trends may provide insight into tubulointerstitial pathology that is not evident through measurement of glomerular filtration rate (GFR) and albumin excretion rate (AER).
We examined longitudinal changes in tubular biomarkers in 2 type 1 diabetes (T1D) cohorts, namely the Renin-Angiotensin System Study (RASS, = 283), including adults with normal GFR and AER and the Preventing Early Renal Loss in Diabetes Study (PERL, = 530), including adults with albuminuria and/or rapid loss of estimated GFR (eGFR). The measurements included plasma kidney injury molecule-1 (KIM-1), soluble tumor necrosis factor receptor 1 (sTNFR1), arginine-citrulline ratio, urine epidermal growth factor (EGF), uromodulin (UMOD), and a tubular secretion score reflecting urinary clearances of 8 proximal tubular secreted molecules.
At baseline, RASS participants' mean age was 30 years and 47% were male, with mean diabetes duration of 11 years, hemoglobin A1c (HbA1c) of 8.6%, iohexol-based measured GFR (iGFR) of 128 ml/min per 1.73 m, and AER of 6 μg/min. PERL participants' mean age was 51 years and 66% were male, with mean diabetes duration of 35 years, HbA1c of 8.2%, iGFR of 68 ml/min per 1.73 m, and AER of 285 μg/min. Tubular biomarkers changed significantly over time as follows: KIM-1 of +5.7 pg/ml/yr, sTNFR1 of +14.2 pg/ml/yr, arginine-citrulline ratio of -0.03 units/yr, and EGF of -0.30 μg/d/yr in RASS; KIM-1 of +7.5 pg/ml/yr, sTNFR1 of +75.0 pg/ml/yr, UMOD of -3.4 mg/d/yr, and tubular secretion score of -0.53 units/yr in PERL. Higher baseline HbA1c and AER were associated with more rapid worsening of select tubular biomarkers in both RASS and PERL.
Tubular biomarkers significantly worsen over time in T1D, potentially reflecting progression of tubulointerstitial pathology.
肾小管生物标志物的变化趋势可能有助于深入了解肾小管间质病理情况,而这通过测量肾小球滤过率(GFR)和白蛋白排泄率(AER)并不明显。
我们在两个1型糖尿病(T1D)队列中研究了肾小管生物标志物的纵向变化,即肾素 - 血管紧张素系统研究(RASS,n = 283),包括GFR和AER正常的成年人,以及糖尿病早期肾脏损失预防研究(PERL,n = 530),包括有蛋白尿和/或估计肾小球滤过率(eGFR)快速下降的成年人。测量指标包括血浆肾损伤分子-1(KIM-1)、可溶性肿瘤坏死因子受体1(sTNFR1)、精氨酸 - 瓜氨酸比值、尿表皮生长因子(EGF)、尿调节素(UMOD),以及反映8种近端肾小管分泌分子尿清除率的肾小管分泌评分。
在基线时,RASS参与者的平均年龄为30岁,47%为男性,平均糖尿病病程为11年,糖化血红蛋白(HbA1c)为8.6%,基于碘海醇测量的GFR(iGFR)为128 ml/min/1.73m²,AER为6 μg/min。PERL参与者的平均年龄为51岁,66%为男性,平均糖尿病病程为35年,HbA1c为8.2%,iGFR为68 ml/min/1.73m²,AER为